To further validate the role of pFAK and pSrc in PPFIBP1-mediated migration and invasion of glioma cells, PP-OE and Ctrl cells were treated either with PF562711 (an inhibitor of pFAK) or Dasatinib (an inhibitor of pSrc). The gene discussed is PPFIBP1; the disease is glioma.